In vivo-induced size transformation of cerium oxide nanoparticles in both lung and liver does not affect long-term hepatic accumulation following pulmonary exposure
Open Access
- 20 August 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (8) , e0202477
Abstract
Recent findings show that cerium oxide (CeO2) nanoparticles may undergo in vivo-induced size transformation with the formation of smaller particles that could result in a higher translocation following pulmonary exposure compared to virtually insoluble particles, like titanium dioxide (TiO2). Therefore, we compared liver deposition of CeO2 and TiO2 nanoparticles of similar primary sizes 1, 28 or 180 days after intratracheal instillation of 162 μg of NPs in female C57BL/6 mice. Mice exposed to 162 μg CeO2 or TiO2 nanoparticles by intravenous injection or oral gavage were included as reference groups to assess the amount of NPs that reach the liver bypassing the lungs and the translocation of NPs from the gastrointestinal tract to the liver, respectively. Pulmonary deposited CeO2 nanoparticles were detected in the liver 28 and 180 days post-exposure and TiO2 nanoparticles 180 days post-exposure as determined by darkfield imaging and by the quantification of Ce and Ti mass concentration by inductively coupled plasma-mass spectrometry (ICP-MS). Ce and Ti concentrations increased over time and 180 days post-exposure the translocation to the liver was 2.87 ± 3.37% and 1.24 ± 1.98% of the initial pulmonary dose, respectively. Single particle ICP-MS showed that the size of CeO2 nanoparticles in both lung and liver tissue decreased over time. No nanoparticles were detected in the liver following oral gavage. Our results suggest that pulmonary deposited CeO2 and TiO2 nanoparticles translocate to the liver with similar calculated translocation rates despite their different chemical composition and shape. The observed particle size distributions of CeO2 nanoparticles indicate in vivo processing over time both in lung and liver. The fact that no particles were detected in the liver following oral exposure showed that direct translocation of nanoparticles from lung to the systemic circulation was the most important route of translocation for pulmonary deposited particles.Keywords
Funding Information
- Danish Working Environment Research Foundation (20110092173-3)
This publication has 60 references indexed in Scilit:
- Titanium dioxide nanoparticles: a review of current toxicological dataParticle and Fibre Toxicology, 2013
- Carbon black nanoparticle instillation induces sustained inflammation and genotoxicity in mouse lung and liverParticle and Fibre Toxicology, 2012
- Determining Transport Efficiency for the Purpose of Counting and Sizing Nanoparticles via Single Particle Inductively Coupled Plasma Mass SpectrometryAnalytical Chemistry, 2011
- Intratracheal instillation of cerium oxide nanoparticles induces hepatic toxicity in male Sprague-Dawley ratsInternational Journal of Nanomedicine, 2011
- Deposition and biokinetics of inhaled nanoparticlesParticle and Fibre Toxicology, 2010
- Effects of prenatal exposure to surface-coated nanosized titanium dioxide (UV-Titan). A study in miceParticle and Fibre Toxicology, 2010
- Biodistribution of gold nanoparticles in mouse lung following intratracheal instillationBMC Chemistry, 2009
- Lung inflammation and genotoxicity following pulmonary exposure to nanoparticles in ApoE-/- miceParticle and Fibre Toxicology, 2009
- Kupffer cells are central in the removal of nanoparticles from the organismParticle and Fibre Toxicology, 2007
- Efficient Elimination of Inhaled Nanoparticles from the Alveolar Region: Evidence for Interstitial Uptake and Subsequent Reentrainment onto Airways EpitheliumEnvironmental Health Perspectives, 2007